What You Should Know: - Accuhealth’s remote patient monitoring platform and 2bPrecise’s precision genetic/genomic data platform announced that it is available in the Epic App Orchard. The App Orchard program enables developers to integrate their healthcare IT solutions with the Epic electronic health record (EHR) using standards-based APIs. - The 2bPrecise platform consumes genetic/genomic data from molecular labs and clinical information from EHRs. It synthesizes
Read More
AccessDX Acquires 2bPrecise from Allscripts for Actionable Precision Medicine Insights
What You Should Know: - AccessDX, a leading diagnostic laboratory, and diagnostic technology company has acquired 2bPrecise, a genomic and healthcare informatics innovator, from Allscripts Healthcare Solutions. This merger comes as advances in genetic research and medicine have driven skyrocketing demand for genetic testing, data, and insights by healthcare providers, laboratories, and consumers around the world. Financial details of the acquisition were not disclosed. - Hospitals, health
Read More
US Orthopedic Alliance Taps 2bPrecise to Power Precision Medicine Program
What You Should Know: 2bPrecise, a precision medicine company, announced that the US Orthopedic Alliance (USOA) is leveraging 2bPrecise’ pharmacogenomics (PGx) solution to help physicians identify potentially dangerous drug-gene interactions. - The 2bPrecise platform will deliver workflow, data management and clinical decision functionality to USOA providers ordering pharmacogenomic tests (PGx). Specifically, doctors can leverage test results to make informed decisions
Read More
Meaningful Use of Genomics Requires Informatics Beyond EMRs
Electronic medical records (EMRs) are widely expected to serve as a cornerstone technology that drives the delivery of modern patient care. But can the EMR alone support all the informatics capabilities required by an ever-evolving healthcare industry? The rapid growth of precision medicine, particularly the use of genetic and genomic information during clinical decision making, is a compelling example that functionality beyond the EMR is required. Not only does genomic data represent a
Read More
Consumer Genetic Tests Accelerate Precision Medicine for Some Providers
Direct-to-consumer (DTC) genetic tests have been on the scene for some time now. The Federal Drug Administration (FDA) approved the first DTC test on three specific BRCA1/BRCA2 breast cancer gene mutations more than two years ago. Six months after that, the agency similarly green-lighted a DTC pharmacogenomic (PGx) test to examine 33 variants for eight different genes that indicate how effectively patients metabolize specific medications. Like many such advances, availability of DTC tests is
Read More
2020 MedTech Breakthrough Award Winners Announced
What You Should Know: - MedTech Breakthrough announces 2020 MedTech Breakthrough Award Winners that recognizes the top companies, people, platforms, and products in the health, fitness, and medical technology industries today. - The 2020 MedTech Breakthrough Awards program is open to all individuals, companies, and organizations involved in producing digital health and medical technology products and services. MedTech
Breakthrough, a market intelligence organization that recognizes
Read More
University Hospitals Taps 2bPrecise to Deliver Genomic Insights
University Hospitals, today announced it, has selected the 2bPrecise® platform to bring genomic data into the clinical workflow, impacting patient care in both acute and ambulatory settings. The 2bPrecise platform is an offering from 2bPrecise LLC, a wholly owned subsidiary of Allscripts. University Hospitals (UH) serves the needs of patients through an integrated network of 18 hospitals, more than 50 outpatient health centers and 200 physician offices in 15 counties throughout northern Ohio.
Read More
